Determinants of Symptomatic Intracranial Progression After an Initial Stereotactic Radiosurgery Course
Authors:
Open Access
- 17 February 2024
- journal article
- research article
- Published by Elsevier in Advances in Radiation Oncology
- Vol. 9 (6) , 101475
Abstract
No abstract availableKeywords
Funding Information
- NIH
This publication has 30 references indexed in Scilit:
- Current multidisciplinary management of brain metastasesCancer, 2020
- Radiation Therapy Practice Patterns for Brain Metastases in the United States in the Stereotactic Radiosurgery EraAdvances in Radiation Oncology, 2020
- Osimertinib in Untreated EGFR -Mutated Advanced Non–Small-Cell Lung CancerNew England Journal of Medicine, 2018
- Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working groupThe Lancet Oncology, 2018
- Stereotactic Radiosurgery in the Management of Limited (1-4) Brain Metasteses: Systematic Review and International Stereotactic Radiosurgery Society Practice GuidelineNeurosurgery, 2017
- Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trialThe Lancet Oncology, 2017
- Multi-institutional Nomogram Predicting Survival Free From Salvage Whole Brain Radiation After Radiosurgery in Patients With Brain MetastasesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2017
- Response assessment criteria for brain metastases: proposal from the RANO groupThe Lancet Oncology, 2015
- Clinical and economic outcomes of patients with brain metastases based on symptoms: An argument for routine brain screening of those treated with upfront radiosurgeryCancer, 2013
- Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor marginJournal of Neurosurgery, 2006